SCHEMBL25916728

SCHEMBL25916728

N#Cc1cccc(C(=O)Nc2ccc(C3(C(=O)Nc4ccc(F)cc4)CCC3)[n+](O)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 8/20 0.54
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.44
CCR2 P41597 1/20 0.41
P2RY2 P41231 1/20 0.41
GPR17 Q13304 1/20 0.41
HDAC1 Q13547 1/20 0.41
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
HTR2B P41595 1/20 0.41
SLC2A1 P11166 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20898715 0.90 IDO1 (0.53) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20898950 0.81 IDO1 (0.61) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20898982 0.78 IDO1 (0.75) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20910452 0.77 IDO1 (0.57) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL29559917 0.77 IDO1 (0.57) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20898935 0.77 IDO1 (0.50) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL29631509 0.74 IDO1 (0.75) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20899512 0.74 IDO1 (0.75) IDO1KDM4EALDH1A1MEN1KMT2A
SCHEMBL20703461 0.74 MEN1 (0.52) IDO1ALDH1A1MEN1KMT2ACCR2
SCHEMBL20910428 0.73 IDO1 (0.78) IDO1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3694503-B1 NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-08-02 EP disclosed